Some senior patients for cancer of the breast does not receive full treatment

Women age 66 with metastatic cancer of the breast above do not always get the full range of mastectomy processes. A study done at MD Anderson Cancer Center in Houston showed that almost half of all women with advanced breast disease do not get radiation therapy after their operation.

Investigators sifted through data from older than 66 38,000 women who have had a mastectomy, between 1999 and 2005, in the group, which had 8 000 patients have Metastatic Breast cancer, but less than 4000 is radiation in addition to surgery. Guidelines as to how radiation shall be placed on women with advanced disease after mastectomy are published during the six years that covered by this study. So experts recognized the benefits of radiation for cancer of the breast, even after removal of the breast-remember that may be affected chest and lymph nodes-but many women do not receive further processing. Dr. Benjamin Smith, co-author of this study, considered the possible reasons behind these results.

Many patients may have been proposed, but decided not to. Before the guidelines were published, most oncologists believe radiation to be ineffective after mastectomy. So the historical affect post-mastectomy radiation may have stood an additional treatment for some women. in other cases, women who are more than 80 years, seems to be least likely to be radiation after surgery of the breast. These patients may consider tradeoffs between quality of life and longevity, and decides that life at the time of the broadcast-plus time-six or more weeks does not seem like the most choice. women may not have lived in close distance to radiation clinic so that light or stay at the hotel during the treatment may not have been an option. Costs of treatment and access to health insurance may also be a factor.

If you have been aged 66 or older with the diagnosis, will want the full spectrum of treatment of advanced breast cancer? or you prefer to stick with the basic surgery and chemotherapy, choosing many patients? What will influence your decision? Please leave your comments below.

View the original article here